RxDoctor Payments Data

Elizabeth Wolfe, NP

Nurse Practitioner · Nashville, TNNPI 1487041521

Payments from drug & device makers

$3,731in general payments, 2019–2025

Across 24 payments — averaging $155.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$3K
  • AbbVie$169
  • Sanofi-aventis U.S. LLC$103
  • Daiichi Sankyo Inc.$72
  • Pharmacyclics LLC, An Abbvie Company$63
  • Legend Biotech USA Inc.$31
  • plus $32 from 2 others

What the payments were for

  • Consulting fees$2,40064%
  • Travel & lodging$68818%
  • Food & beverage$64317%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,731 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$8,797
Medicare patients
54
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrevymisLetermovir17$129,393
VenclextaVenetoclax14$63,794
Posaconazole17$30,928
Voriconazole13$2,460
Acyclovir92$1,973
Tacrolimus22$1,137
Dronabinol11$1,107
Fluconazole15$786
Dapsone13$657
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim62$416
Prochlorperazine Maleate18$215
Hydrocortisone14$210
Levofloxacin14$192
Potassium Chloride13$162
Gabapentin18$154

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVenclexta$169$63,79414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →